Navigation Links
Cumberland Pharmaceuticals Reports First Quarter 2011 Financial Results
Date:5/4/2011

NASHVILLE, Tenn., May 4, 2011 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced first quarter 2011 financial results.

Net Revenue:  For the three months ended March 31, 2011, net revenue was $10.7 million, up from $10.1 million during the corresponding period in 2010. Revenue grew year-over-year despite a brief, planned halt in shipments of Acetadote during the launch of the new product formulation.

Operating Expenses:  Total operating expenses for the three months ended March 31, 2011, were comparable to the prior year period at $9.3 million. This was due to the net effect of decreases in selling and marketing expense and cost of products sold, offset by increases in research and development and general and administrative expenses.

EBITDA:  Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) were $1.7 million for the first quarter in 2011, up from $1.0 million for the prior year period. This growth was attributable to the increase in net revenue and consistent total operating expenses.

Net Income:  Net income attributable to common shareholders for the quarter ending March 31, 2011, was $0.7 million, or $0.03 per diluted share, up 122% from net income of $0.3 million, or $0.02 per diluted share, for the same period in 2010.

Balance Sheet:  As of March 31, 2011, Cumberland had $66.0 million in cash and cash equivalents, compared to $65.9 million at December 31, 2010. Total assets at March 31, 2011, were $91.6 million. As of March 31, 2011, Cumberland had total debt of $6.5 million, including a current portion of $2.7 million, compared to $7.2 million in total debt at the end of 2010.

"The first quarter of 2011 was marked by s
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
2. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
3. Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting
4. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
5. Cumberland Pharmaceuticals Appoints Tan Cheow Choon as Director of International Business
6. Cumberland Pharmaceuticals to Announce 2010 Financial Results on March 8, 2011
7. Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote
8. Cumberland Pharmaceuticals Announces Joey Jacobs Has Joined Its Board of Directors
9. Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials
10. Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results
11. Cumberland Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 11, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Kingdom , Oct. 30, 2014 Molecular ... CBRX ) and Maryland ... developers with improved efficiency during clinical development that will ... next week. This partnership extends ... platform, which it launched earlier this month. The company ...
(Date:10/30/2014)... Oct. 30, 2014   Auxilium Pharmaceuticals , ... integrated specialty biopharmaceutical company, today announced financial results ... The Company highlighted important corporate, commercial, regulatory and ... "We are very pleased with the continued ... products in our portfolio this quarter, especially the ...
(Date:10/30/2014)... Today, DripDrop, the first great tasting ... awarded a two-year contract, effective Sept. 1, from ... the more than 100,000 members and affiliates of ... DripDrop also received an Innovative ... who attended the recent Novation 2014 Innovative Technology ...
Breaking Medicine Technology:Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 3Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 4Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 5Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 6Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 7Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 8Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 9Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 10Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 11Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 12Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 13Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 14Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 15Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 16Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 17Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 18Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 19Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 20Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 21Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 22DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 2DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 3DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 4
... JACKSON, Miss., Dec. 10 The Pharmaceutical,Research and ... on,medicines in the research pipeline for major diseases ... The report found,that America,s pharmaceutical research companies are ... that disproportionately affect African,Americans or diseases that are ...
... that Long-Term Soliris Therapy Continued to Be Associated with, Reductions in Thrombosis and Improvements ... ... (ASH) Annual Meeting ... 891-III, CHESHIRE, Conn., Dec. 10 Patients with a rare,blood disorder called paroxysmal ...
Cached Medicine Technology:New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline 2New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline 3Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 2Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 3Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 4Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 5Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 6Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 7Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 8Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 9Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH 10
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- When it comes to heart ... men to delay care when they have symptoms that spell ... to the hospital with a more severe or advanced stage ... study author Catherine Kreatsoulas, a Fulbright Scholar and research fellow ... news release from the Heart and Stroke Foundation of Canada. ...
(Date:10/30/2014)... Norton HealthDay Reporter WEDNESDAY, ... plastics, chemical during pregnancy may have effects on genital development ... that baby boys born to moms with greater exposure to ... distance -- the space between the genitals and anus. Anogenital ... marker of exposure to androgens ("male" hormones) during pregnancy. ...
(Date:10/30/2014)... 2014 (HealthDay News) -- Many U.S. colleges have ... though tanning increases the risk for skin cancer, ... adults, particularly white women, so colleges should adopt ... researchers said. "Public health efforts are needed ... of the harms that indoor tanning poses to ...
(Date:10/30/2014)... Americans, opinions about the Affordable Care Act are sharply ... Democratic voters are strongly in favor of the Affordable ... of Democrats want the next Congress to move ahead ... the current law, while 44 percent want to expand ... one-third want the law repealed, and 27 percent want ...
(Date:10/30/2014)... the fact that a patient,s body is only ... a third of cancer patients experience psychosocial distress ... And, increasingly, care providers are exploring phone- and ... health challenges. A University of Colorado Cancer Center ... asks an important question: after decades of ...
Breaking Medicine News(10 mins):Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 2Health News:Plastics' Chemical May Affect Baby Boys' Genital Development 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2Health News:Voters' Views on Obamacare Split Along Party Lines 2Health News:Decades of research: Effectiveness of phone counseling for cancer patients still unknown 2
... New medicines should be granted a provisional safety ... proven amongst the wider //population, experts have said ... ,Recent experience with Vioxx and some other ... after marketing, has shown that reliance on pre-marketing ...
... more he or she consumes sugary drinks, and extra calories, ... increase in TV viewing per day, we found higher intakes ... and total calories (46.3 more kcal/day)," said Sonia Miller, B.A., ... Harvard Medical School. ,Miller and her colleagues ...
... who smoke during pregnancy can cause permanent vascular damage ... and heart attack, according to a research. ... study showed that participants who were exposed to smoke ... damage that could be detected in young adulthood. ...
... of kidney tumors – cryoablation – is as effective ... was presented at the Society of Interventional Radiology’s 32nd ... shows that percutaneous cryoablation results in a slightly lower ... no major complications, and a 59.5 percent lower hospital ...
... pledged to eradicate the polio in the last four endemic ... long as needed till the last trace of the paralyzing ... hopefully final assault on polio, the United Nations health agency ... and then sustain for as long as needed, vaccination levels ...
... about half of all visits to psychotherapists, and most ... couples.// The therapist helps the couple work on eliminating ... conflict, explains the March 2007 issue of the Harvard ... little use of psychiatric diagnosis, but they do use ...
Cached Medicine News:Health News:Time to Overhaul Australia's Medicines Safety Surveillance System 2Health News:Excessive TV Viewing Linked to Poor Eating Habits in Children 2Health News:Excessive TV Viewing Linked to Poor Eating Habits in Children 3Health News:Pregnant Smokers Raise Their Child's Risk of Stroke, Heart Attack 2Health News:Pregnant Smokers Raise Their Child's Risk of Stroke, Heart Attack 3Health News:Freezing Kidney Tumors Effective and Less Expensive Than Laparoscopy 2Health News:UN Health Agency, Partners Seek Total Eradication of Polio 2
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
... The InstaCheck® multi-drug test ... simply and easily. Negative results ... few as 3 minutes; positive ... A simple, one-time urine sample ...
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
AccuSign® DOA Series Opiates Test...
Medicine Products: